Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China flag China · Delayed Price · Currency is CNY
33.80
-0.04 (-0.12%)
Apr 2, 2025, 2:45 PM CST

SHE:002294 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Cash & Equivalents
1,1251,3222,6703,236865.13
Upgrade
Short-Term Investments
-695.51531.58--
Upgrade
Trading Asset Securities
733.86186.06328.3660214.59
Upgrade
Cash & Short-Term Investments
1,8592,2043,5303,2961,080
Upgrade
Cash Growth
-15.62%-37.58%7.12%205.25%-18.20%
Upgrade
Accounts Receivable
565.87545.38557.72474.03526.57
Upgrade
Other Receivables
23.8521.0123.4155.4830.63
Upgrade
Receivables
589.72566.39581.12629.51557.2
Upgrade
Inventory
506.76490.86543.53420.45391.56
Upgrade
Prepaid Expenses
----1.13
Upgrade
Other Current Assets
1,06952.4356.3658102.31
Upgrade
Total Current Assets
4,0253,3134,7114,4042,132
Upgrade
Property, Plant & Equipment
1,4301,4571,5061,6381,507
Upgrade
Long-Term Investments
1,2061,701963.07854.48835.67
Upgrade
Goodwill
10.9110.9160.5387.1487.14
Upgrade
Other Intangible Assets
1,3351,318965.461,0481,244
Upgrade
Long-Term Deferred Tax Assets
151.2487.488.4282.0198.26
Upgrade
Long-Term Deferred Charges
1,5971,4161,3441,047816.84
Upgrade
Other Long-Term Assets
710.9993.31116.6483.09197.43
Upgrade
Total Assets
10,4669,3979,7559,2446,918
Upgrade
Accounts Payable
126.09156.01219.65187.67223.39
Upgrade
Accrued Expenses
262.96491.34558.35487.02327.04
Upgrade
Short-Term Debt
12040177.1963300.26
Upgrade
Current Portion of Long-Term Debt
9.7----
Upgrade
Current Portion of Leases
-10.9311.466.99-
Upgrade
Current Income Taxes Payable
39.4610.4928.9237.210.7
Upgrade
Current Unearned Revenue
38.2229.5542.6697.9953.23
Upgrade
Other Current Liabilities
516.5376.77565.4132.98182.37
Upgrade
Total Current Liabilities
1,113815.081,6041,0131,097
Upgrade
Long-Term Debt
----90
Upgrade
Long-Term Leases
4.1812.5419.589.11-
Upgrade
Long-Term Unearned Revenue
142.0484.1198.5393.7189.61
Upgrade
Long-Term Deferred Tax Liabilities
20.9713.0427.18-19.82
Upgrade
Other Long-Term Liabilities
433.14416.4729.6482.5730.41
Upgrade
Total Liabilities
1,7131,3411,7791,1981,327
Upgrade
Common Stock
1,1151,1151,1151,1151,046
Upgrade
Additional Paid-In Capital
1,9281,9001,8661,930-
Upgrade
Retained Earnings
5,6205,5645,5295,3304,798
Upgrade
Treasury Stock
--602.16-602.16-327.86-327.75
Upgrade
Comprehensive Income & Other
49.342.2233.24-13.41-7.69
Upgrade
Total Common Equity
8,7128,0197,9418,0345,508
Upgrade
Minority Interest
40.1736.4335.8111.9183.33
Upgrade
Shareholders' Equity
8,7528,0557,9778,0465,592
Upgrade
Total Liabilities & Equity
10,4669,3979,7559,2446,918
Upgrade
Total Debt
133.8863.47208.2379.1390.26
Upgrade
Net Cash (Debt)
1,7252,1403,3223,217689.46
Upgrade
Net Cash Growth
-19.38%-35.58%3.28%366.56%-29.40%
Upgrade
Net Cash Per Share
1.551.923.023.010.68
Upgrade
Filing Date Shares Outstanding
1,1321,0911,0911,1031,029
Upgrade
Total Common Shares Outstanding
1,1321,0911,0911,1031,029
Upgrade
Working Capital
2,9122,4983,1083,3911,035
Upgrade
Book Value Per Share
7.707.357.287.295.36
Upgrade
Tangible Book Value
7,3666,6906,9156,8984,177
Upgrade
Tangible Book Value Per Share
6.516.136.346.264.06
Upgrade
Buildings
-1,2181,2081,218946.22
Upgrade
Machinery
-1,2031,1381,109923.7
Upgrade
Construction In Progress
-34.3537.694.13343.78
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.